Corrigendum to: Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases

Affiliations

• ¹ Global Health, GSK, Brentford, UK.
• ² Corporate Responsibility, Merck & Co., Inc., Kenilworth, NJ, USA.
• ³ Bridges to Development, Seattle, Washington, USA.
• ⁴ International Federation of Pharmaceutical Manufacturers and Associations, Geneva, Switzerland.
• ⁵ Adrian Hopkins Consulting, Gravesend, Kent, UK.
• ⁶ Global Health & Patient Access, Pfizer, Inc. New York, NY, USA.
• ⁷ Johnson & Johnson Global Public Health, New Brunswick, NJ, USA.
• ⁸ Global Health, Group Corporate Affairs Merck KGaA, Darmstadt, Germany.
• ⁹ Global Health Programs, Sanofi, Paris, France.
• ¹⁰ Global Patient Solutions Africa, Gilead Sciences, Foster City, CA, USA.
• ¹¹ Neglected Tropical Disease Programs, Bayer AG Pharmaceuticals, Berlin, Germany.
• ¹² Sustainability, Eisai Co. Ltd, Tokyo, Japan.
• ¹³ Novartis Global Health & Corporate Responsibility, Basel, Switzerland.
• ¹⁴ Department of Control of Neglected Tropical Diseases, WHO Geneva, Geneva, Switzerland.
• ¹⁵ Department of Communicable Diseases WHO Regional Office for South-East Asia, Delhi, India.
• ¹⁶ Expanded Special Project for Elimination of NTDs (ESPEN) WHO Regional Office for Africa, Brazzaville, Congo.
• ¹⁷ Division of Programs for Disease Control WHO Regional Office for the Western Pacific, Manila, Philippines.
• ¹⁸ NTD Support Centre, Task Force for Global Health Atlanta, USA.